Latest Ischaemic heart disease Stories

2011-07-08 14:03:57

New research published online today in Circulation Research found that injections of adult patients' own CD34+ stem cells reduced reports of angina episodes and improved exercise tolerance time in patients with chronic, severe refractory angina (severe chest discomfort that did not respond to other therapeutic options).

2011-05-26 06:55:40

A new study reveals having a CT angiography test leads to more prescriptions for medications, more tests, and more procedures.

2011-03-24 14:29:41

A new study of coronary artery calcium scanning – a simple, noninvasive test that gives patients baseline information about plaque in their coronary arteries—has shown that the scan helps them make heart-healthy lifestyle changes and lower their heart disease risk factors.

2011-02-07 21:40:36

Never before has a therapy proven more beneficial for women than men in preventing heart disease – until now.

2011-01-25 12:58:27

Two relatively simple methods, an ultrasound investigation and a blood test to measure the level of a substance known as BNP, can predict survival and future heart failure following acute coronary syndromes.

2011-01-19 13:59:09

A European study investigating the links between diet and disease has found that people who consume more fruit and vegetables have a lower risk of dying from ischaemic heart disease – the most common form of heart disease and one of the leading causes of death in Europe.

2010-12-13 03:19:00

TEL AVIV, Israel, December 13, 2010 /PRNewswire-FirstCall/ -- Biological Signal Processing Ltd.

2010-11-22 06:01:00

BAAR, Switzerland and TEL AVIV, November 22, 2010 /PRNewswire-FirstCall/ -- SCHILLER AG, a leading international manufacturer and supplier of cardiopulmonary diagnostics and BSP Biological Signal Processing Ltd., a medical device company that develops and markets innovative solutions for noninvasive cardiac diagnosis and monitoring , announced on November 8th, 2010 the signing of an agreement to jointly develop a new product line based on BSP's HyperQ(TM) technology.

2010-08-30 06:25:00

PARIS, August 30, 2010 /PRNewswire/ -- - Composite Primary Endpoint: Risk Reduction of 17% (Non-Statistically Significant ) in Death, Complication of Myocardial Infraction, Procedure Failure or Major Bleeding (p=0.07) - Main Secondary Composite Efficacy Endpoint: 40% Reduction of Death, Recurrent Acute Coronary Syndrome or Re-Intervention (p=0.01) The international ATOLL study sponsored by the Assistance Publique - Hopitaux de Paris showed that enoxaparin reduced the composite...

Word of the Day
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.